BIO-SOLIFENACIN DIN 02516519
Health Canada record
| Active ingredient(s) | SOLIFENACIN SUCCINATE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G04BD08 SOLIFENACIN |
| Original market date | 13-Apr-2022 |
| Current status date | 13-Jan-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Biomed Pharma — licence 101061, currently licensed, last inspection rating C (2024-06-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SOLIFENACIN SUCCINATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02439344 | ACH-SOLIFENACIN SUCCINATE | ACCORD HEALTHCARE INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02439352 | ACH-SOLIFENACIN SUCCINATE | ACCORD HEALTHCARE INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02446375 | AURO-SOLIFENACIN | AURO PHARMA INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02446383 | AURO-SOLIFENACIN | AURO PHARMA INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02516527 | BIO-SOLIFENACIN | BIOMED PHARMA | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02428938 | JAMP SOLIFENACIN SUCCINATE | JAMP PHARMA CORPORATION | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02428911 | JAMP SOLIFENACIN SUCCINATE | JAMP PHARMA CORPORATION | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02417731 | PMS-SOLIFENACIN | PHARMASCIENCE INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02417723 | PMS-SOLIFENACIN | PHARMASCIENCE INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02493047 | PRZ-SOLIFENACIN | PHARMARIS CANADA INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02493039 | PRZ-SOLIFENACIN | PHARMARIS CANADA INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02399032 | SANDOZ SOLIFENACIN | SANDOZ CANADA INCORPORATED | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02399040 | SANDOZ SOLIFENACIN | SANDOZ CANADA INCORPORATED | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02458144 | SOLIFENACIN | PRO DOC LIMITEE | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02458268 | SOLIFENACIN | SANIS HEALTH INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02458241 | SOLIFENACIN | SANIS HEALTH INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02458152 | SOLIFENACIN | PRO DOC LIMITEE | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02403595 | SOLIFENACIN SUCCINATE | JUBILANT GENERICS LIMITED | Tablet | SOLIFENACIN SUCCINATE 5 MG | Approved |
| 02403609 | SOLIFENACIN SUCCINATE | JUBILANT GENERICS LIMITED | Tablet | SOLIFENACIN SUCCINATE 10 MG | Approved |
| 02471019 | SOLIFENACIN SUCCINATE TABLETS | STRIDES PHARMA CANADA INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Approved |
| 02471000 | SOLIFENACIN SUCCINATE TABLETS | STRIDES PHARMA CANADA INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Approved |
| 02437988 | TARO-SOLIFENACIN | SUN PHARMA CANADA INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02437996 | TARO-SOLIFENACIN | SUN PHARMA CANADA INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02397900 | TEVA-SOLIFENACIN | TEVA CANADA LIMITED | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02397919 | TEVA-SOLIFENACIN | TEVA CANADA LIMITED | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02277263 | VESICARE | ASTELLAS PHARMA CANADA INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Marketed |
| 02277271 | VESICARE | ASTELLAS PHARMA CANADA INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Marketed |
| 02422239 | ACT SOLIFENACIN | ACTAVIS PHARMA COMPANY | Tablet | SOLIFENACIN SUCCINATE 5 MG | Cancelled Post Market |
| 02422247 | ACT SOLIFENACIN | ACTAVIS PHARMA COMPANY | Tablet | SOLIFENACIN SUCCINATE 10 MG | Cancelled Post Market |
| 02423383 | APO-SOLIFENACIN | APOTEX INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Cancelled Post Market |
| 02423375 | APO-SOLIFENACIN | APOTEX INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Cancelled Post Market |
| 02459221 | DOM-SOLIFENACIN | DOMINION PHARMACAL | Tablet | SOLIFENACIN SUCCINATE 5 MG | Cancelled Pre Market |
| 02459248 | DOM-SOLIFENACIN | DOMINION PHARMACAL | Tablet | SOLIFENACIN SUCCINATE 10 MG | Cancelled Pre Market |
| 02424347 | JAMP-SOLIFENACIN | JAMP PHARMA CORPORATION | Tablet | SOLIFENACIN SUCCINATE 10 MG | Dormant |
| 02424339 | JAMP-SOLIFENACIN | JAMP PHARMA CORPORATION | Tablet | SOLIFENACIN SUCCINATE 5 MG | Dormant |
| 02529696 | M-SOLIFENACIN SUCCINATE | MANTRA PHARMA INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Cancelled Post Market |
| 02529718 | M-SOLIFENACIN SUCCINATE | MANTRA PHARMA INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Cancelled Post Market |
| 02443171 | MINT-SOLIFENACIN | MINT PHARMACEUTICALS INC | Tablet | SOLIFENACIN SUCCINATE 5 MG | Cancelled Post Market |
| 02443198 | MINT-SOLIFENACIN | MINT PHARMACEUTICALS INC | Tablet | SOLIFENACIN SUCCINATE 10 MG | Cancelled Post Market |
| 02448335 | SOLIFENACIN SUCCINATE TABLETS | MDA INC. | Tablet | SOLIFENACIN SUCCINATE 5 MG | Cancelled Post Market |
| 02448343 | SOLIFENACIN SUCCINATE TABLETS | MDA INC. | Tablet | SOLIFENACIN SUCCINATE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36724 | 2026-01-13 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
| 26004 | 2021-06-04 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for SOLIFENACIN SUCCINATE
25 valid EDQM Certificates of Suitability from 25 holders. 26 active FDA Drug Master Files.
Request a quote for BIO-SOLIFENACIN